Jaguar Health, Inc.
JAGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,437 | $1,168 | $36 | $195 |
| - Cash | $8,002 | $6,469 | $5,469 | $17,051 |
| + Debt | $36,526 | $37,094 | $34,835 | $29,365 |
| Enterprise Value | $35,961 | $31,793 | $29,402 | $12,509 |
| Revenue | $11,689 | $9,761 | $11,956 | $4,335 |
| % Growth | 19.8% | -18.4% | 175.8% | – |
| Gross Profit | $9,734 | $7,724 | $9,937 | $2,002 |
| % Margin | 83.3% | 79.1% | 83.1% | 46.2% |
| EBITDA | -$36,662 | -$32,760 | -$33,380 | -$42,366 |
| % Margin | -313.6% | -335.6% | -279.2% | -977.3% |
| Net Income | -$38,492 | -$41,300 | -$47,454 | -$52,595 |
| % Margin | -329.3% | -423.1% | -396.9% | -1,213.3% |
| EPS Diluted | -130.69 | -2,685 | -4,070,250 | -11,370,375 |
| % Growth | 95.1% | 99.9% | 64.2% | – |
| Operating Cash Flow | -$29,384 | -$33,242 | -$33,104 | -$34,970 |
| Capital Expenditures | -$231 | $0 | -$1,675 | -$6 |
| Free Cash Flow | -$29,615 | -$33,242 | -$34,779 | -$34,976 |